Literature DB >> 16873262

Infection of human airway epithelium by human and avian strains of influenza a virus.

Catherine I Thompson1, Wendy S Barclay, Maria C Zambon, Raymond J Pickles.   

Abstract

We describe the characterization of influenza A virus infection of an established in vitro model of human pseudostratified mucociliary airway epithelium (HAE). Sialic acid receptors for both human and avian viruses, alpha-2,6- and alpha-2,3-linked sialic acids, respectively, were detected on the HAE cell surface, and their distribution accurately reflected that in human tracheobronchial tissue. Nonciliated cells present a higher proportion of alpha-2,6-linked sialic acid, while ciliated cells possess both sialic acid linkages. Although we found that human influenza viruses infected both ciliated and nonciliated cell types in the first round of infection, recent human H3N2 viruses infected a higher proportion of nonciliated cells in HAE than a 1968 pandemic-era human virus, which infected proportionally more ciliated cells. In contrast, avian influenza viruses exclusively infected ciliated cells. Although a broad-range neuraminidase abolished infection of HAE by human parainfluenza virus type 3, this treatment did not significantly affect infection by influenza viruses. All human viruses replicated efficiently in HAE, leading to accumulation of nascent virus released from the apical surface between 6 and 24 h postinfection with a low multiplicity of infection. Avian influenza A viruses also infected HAE, but spread was limited compared to that of human viruses. The nonciliated cell tropism of recent human H3N2 viruses reflects a preference for the sialic acid linkages displayed on these cell types and suggests a drift in the receptor binding phenotype of the H3 hemagglutinin protein as it evolves in humans away from its avian virus precursor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873262      PMCID: PMC1563802          DOI: 10.1128/JVI.00384-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Functional balance between haemagglutinin and neuraminidase in influenza virus infections.

Authors:  Ralf Wagner; Mikhail Matrosovich; Hans-Dieter Klenk
Journal:  Rev Med Virol       Date:  2002 May-Jun       Impact factor: 6.989

Review 2.  Protein Explorer: easy yet powerful macromolecular visualization.

Authors:  Eric Martz
Journal:  Trends Biochem Sci       Date:  2002-02       Impact factor: 13.807

Review 3.  Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding.

Authors:  Mikhail Matrosovich; Hans-Dieter Klenk
Journal:  Rev Med Virol       Date:  2003 Mar-Apr       Impact factor: 6.989

Review 4.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

5.  Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology.

Authors:  Liqun Zhang; Mark E Peeples; Richard C Boucher; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides.

Authors:  E Nobusawa; H Ishihara; T Morishita; K Sato; K Nakajima
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

7.  Human-specific regulation of alpha 2-6-linked sialic acids.

Authors:  Pascal Gagneux; Monica Cheriyan; Nancy Hurtado-Ziola; Els C M Brinkman van der Linden; Dan Anderson; Harold McClure; Ajit Varki; Nissi M Varki
Journal:  J Biol Chem       Date:  2003-09-18       Impact factor: 5.157

8.  Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.

Authors:  Yacine Abed; Anne-Marie Bourgault; Robert J Fenton; Peter J Morley; David Gower; Ian J Owens; Margaret Tisdale; Guy Boivin
Journal:  J Infect Dis       Date:  2002-09-30       Impact factor: 5.226

9.  H5N1 Virus Attachment to Lower Respiratory Tract.

Authors:  Debby van Riel; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Ab D M E Osterhaus; Thijs Kuiken
Journal:  Science       Date:  2006-03-23       Impact factor: 47.728

10.  Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs.

Authors:  Larisa Mochalova; Alexandra Gambaryan; Julia Romanova; Alexander Tuzikov; Alexander Chinarev; Dietmar Katinger; Herman Katinger; Andrej Egorov; Nicolai Bovin
Journal:  Virology       Date:  2003-09-01       Impact factor: 3.616

View more
  136 in total

1.  Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells.

Authors:  Rachel E Owen; Eriko Yamada; Catherine I Thompson; Louisa J Phillipson; Clare Thompson; Elizabeth Taylor; Maria Zambon; Helen M I Osborn; Wendy S Barclay; Persephone Borrow
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.

Authors:  Andrew J Burnham; Tatiana Baranovich; Bindumadhav M Marathe; Jianling Armstrong; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

3.  Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures.

Authors:  Hui Zeng; Cynthia S Goldsmith; Taronna R Maines; Jessica A Belser; Kortney M Gustin; Andrew Pekosz; Sherif R Zaki; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

4.  Neonatal irradiation sensitizes mice to delayed pulmonary challenge.

Authors:  Carl J Johnston; Casey M Manning; Javier Rangel-Moreno; Troy D Randall; Eric Hernady; Jacob N Finkelstein; Jacqueline P Williams
Journal:  Radiat Res       Date:  2012-03-15       Impact factor: 2.841

5.  Systematic assembly of a full-length infectious clone of human coronavirus NL63.

Authors:  Eric F Donaldson; Boyd Yount; Amy C Sims; Susan Burkett; Raymond J Pickles; Ralph S Baric
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

Review 6.  H5N1 receptor specificity as a factor in pandemic risk.

Authors:  James C Paulson; Robert P de Vries
Journal:  Virus Res       Date:  2013-04-22       Impact factor: 3.303

7.  Human airway epithelial cell culture to identify new respiratory viruses: coronavirus NL63 as a model.

Authors:  Bridget S Banach; Jan M Orenstein; Linda M Fox; Scott H Randell; Anne H Rowley; Susan C Baker
Journal:  J Virol Methods       Date:  2008-12-05       Impact factor: 2.014

8.  Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium.

Authors:  Guadalupe Ayora-Talavera; Holly Shelton; Margaret A Scull; Junyuan Ren; Ian M Jones; Raymond J Pickles; Wendy S Barclay
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

9.  Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity.

Authors:  Haichen Song; Hongquan Wan; Yonas Araya; Daniel R Perez
Journal:  Virol J       Date:  2009-08-14       Impact factor: 4.099

10.  Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

Authors:  Gallen B Triana-Baltzer; Larisa V Gubareva; John M Nicholls; Melissa B Pearce; Vasiliy P Mishin; Jessica A Belser; Li-Mei Chen; Renee W Y Chan; Michael C W Chan; Maria Hedlund; Jeffrey L Larson; Ronald B Moss; Jacqueline M Katz; Terrence M Tumpey; Fang Fang
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.